Federal · 119th Congress
PEAT Act of 2026
Policy areaHealth
The Congressional Research Service has not published a summary of this measure.
Read the text of the bill →Sponsor
Cosponsors12
Diana HarshbargerRU.S. Representative · 1st District · TN
Morgan LuttrellRU.S. Representative · 8th District · TX
Brian BabinRU.S. Representative · 36th District · TX
Mike KennedyRU.S. Representative · 3rd District · UT
John R. CarterRU.S. Representative · 31st District · TX
Abraham J. HamadehRU.S. Representative · 8th District · AZ
Randy K. Weber, Sr.RU.S. Representative · 14th District · TX
Troy E. NehlsRU.S. Representative · 22nd District · TX
Michael T. McCaulRU.S. Representative · 10th District · TX
Earl L. "Buddy" CarterRU.S. Representative · 1st District · GA
Ro KhannaDU.S. Representative · 17th District · CA
Nicholas A. LangworthyRU.S. Representative · 23rd District · NYOther titles3
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.Official Title as Introduced
PEAT Act of 2026Short Title(s) as Introduced
Protecting Equal Access to Thyroid Act of 2026Short Title(s) as Introduced
Legislative history2
Apr 30, 2026
HouseReferred to the House Committee on Energy and Commerce.
Apr 30, 2026
IntroducedIntroduced in House